Precision Public Health in China: Opportunities and Challenges

[1]

Taylor-Robinson D, Kee F. Precision public health—the Emperor’s new clothes. Int J Epidemiol 2019;48(1):1 − 6. http://dx.doi.org/10.1093/ije/dyy184.

[2]

Chowkwanyun M, Bayer R, Galea S. “Precision” public health—between novelty and hype. N Engl J Med 2018;379(15):1398 − 400. http://dx.doi.org/10.1056/NEJMp1806634.

[3]

Horton R. Offline: in defence of precision public health. Lancet 2018;392(10157):1504. http://dx.doi.org/10.1016/S0140-6736(18)32741-7.

[4]

Khoury MJ, Engelgau M, Chambers AD, Mensah GA. Beyond public health genomics: can big data and predictive analytics deliver precision public health? Public Health Genomics 2018;21(5−6):244 − 50.http://dx.doi.org/10.1159/000501465.

[5]

Khoury MJ, Bowen MS, Clyne M, Dotson WD, Gwinn ML, Green RF, et al. From public health genomics to precision public health: a 20-year journey. Genet Med 2018;20(6):574 − 82. http://dx.doi.org/10.1038/gim.2017.211.

[6]

Weeramanthri TS, Dawkins HJS, Baynam G, Bellgard M, Gudes O, Semmens JB. Editorial: precision public health. Front Public Health 2018;6:121. http://dx.doi.org/10.3389/fpubh.2018.00121.

[7]

Rasmussen SA, Khoury MJ, Del Rio C. Precision public health as a key tool in the COVID-19 response. JAMA 2020;324(10):933 − 4. http://dx.doi.org/10.1001/jama.2020.14992.

[8]

Karthikeyan S, Levy JI, De Hoff P, Humphrey G, Birmingham A, Jepsen K, et al. Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission. Nature 2022.http://dx.doi.org/10.1038/s41586-022-05049-6.

[9]

Saravanan KA, Panigrahi M, Kumar H, Rajawat D, Nayak SS, Bhushan B, et al. Role of genomics in combating COVID-19 pandemic. Gene 2022;823:146387. http://dx.doi.org/10.1016/j.gene.2022.146387.

[10]

Evangelatos N, Satyamoorthy K, Levidou G, Bauer P, Brand H, Kouskouti C, et al. Multi-omics research trends in sepsis: a bibliometric, comparative analysis between the united states, the european union 28 member states, and China. OMICS J Integr Biol 2018;22(3):190 − 7. http://dx.doi.org/10.1089/omi.2017.0192.

[11]

Collins FS, Morgan M, Patrinos A. The human genome project: lessons from large-scale biology. Science 2003;300(5617):286 − 90. http://dx.doi.org/10.1126/science.1084564.

[12]

Liu PP, Lu H, Li S, Moureau G, Deng YQ, Wang YY, et al. Genomic and antigenic characterization of the newly emerging Chinese duck egg-drop syndrome flavivirus: genomic comparison with Tembusu and Sitiawan viruses. J Gen Virol 2012;93(10):2158 − 70. http://dx.doi.org/10.1099/vir.0.043554-0.

[13]

Chen ZM, Chen JS, Collins R, Guo Y, Peto R, Wu F, et al. China kadoorie biobank of 0. 5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 2011;40(6):1652 − 66. http://dx.doi.org/10.1093/ije/dyr120.

[14]

Huang T, Gao WJ, Lv J, Yu CQ, Wu T, Wang SF, et al. The Chinese national twin registry: a unique data source for systems epidemiology of complex disease. Twin Res Hum Genet 2019;22(6):482 − 5. http://dx.doi.org/10.1017/thg.2019.85.

[15]

Illumina. Video: A Golden Age for China’s NGS Industry. 2021.https://www.illumina.com/content/illumina-marketing/amr/en_US/company/news-center/feature-articles/a-golden-age-for-chinas-ngs-industry.html. [2022-7-10].

[16]

Sun L, Manchanda R, Legood R, Yang L. Using genetic testing at cancer diagnosis for breast cancer control. China CDC Wkly 2022;4(32):711 − 4. http://dx.doi.org/10.46234/ccdcw2022.148.

[17]

Zhu C. Demand for direct-to-consumer genetic testing services in China and its implications for precision public health—China, 2021. China CDC Wkly 2022;4(32):715 − 9. http://dx.doi.org/10.46234/ccdcw2022.149.

[18]

Jiang S. A scoping review of global guidelines for the disclosure of secondary genomic findings to inform the establishment of guidelines in China. China CDC Wkly 2022;4(32):697 − 705. http://dx.doi.org/10.46234/ccdcw2022.146.

[19]

Chen Z, Jiang W, Xu J, Jiang L, Wang G. Ethical, legal, and social implications of genomics in China: a scoping review and implications for precision public health. China CDC Wkly 2022;4(32):706 − 10. http://dx.doi.org/10.46234/ccdcw2022.147.

[20]

Khoury MJ, Bowen S, Dotson WD, Drzymalla E, Green RF, Goldstein R, et al. Health equity in the implementation of genomics and precision medicine: a public health imperative. Genet Med 2022.http://dx.doi.org/10.1016/j.gim.2022.04.009.